Business
Pfizer to seek vaccine approval in November – Bangkok Post
WASHINGTON” The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after…
WASHINGTON” The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.
The company said it hopes to move ahead with the vaccine after safety data is available in the third week of November, immediately lifting the company’s shares two percent in the US.
“So let me be clear, assuming positive data, Pfizer will apply for Emergency Authorisation Use in t…
-
Business16 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News14 hours agoSudden death investigation, Maroochydore – Sunshine Coast
-
General21 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’